Kushlinskii NE - Search Results

1

Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer.

Braga EA, Loginov VI, Burdennyi AM, Filippova EA, Pronina IV, Kurevlev SV, Kazubskaya TP, Kushlinskii DN, Utkin DO, Ermilova VD, Kushlinskii NE. Braga EA, et al. Among authors: kushlinskii dn, kushlinskii ne. Bull Exp Biol Med. 2018 Jan;164(3):351-355. doi: 10.1007/s10517-018-3988-y. Epub 2018 Jan 9. Bull Exp Biol Med. 2018. PMID: 29313235

2

[Relationship between androgen and estrogen receptors and clinico-morphological characteristics of prostatic cancer].

Bassalyk LS, Petrova AS, Ermilova VD, Sokolova VK, Kushlinskiĭ NE. Bassalyk LS, et al. Among authors: kushlinskii ne. Arkh Patol. 1983;45(2):23-8. Arkh Patol. 1983. PMID: 6847409 Russian.

3

[Androgen receptors in the cytosol fraction of prostatic neoplasms and their clinical significance].

Kushlinskii' NE, Gorilovskii' LM, Ermilova VD, Svetozarskii' NL, Bukharkin BV, Degtiar' VG. Kushlinskii' NE, et al. Biull Eksp Biol Med. 1996 Oct;122(10):432-6. Biull Eksp Biol Med. 1996. PMID: 9081444 Russian. No abstract available.

4

Modern methods for diagnosis and monitoring of nephrotoxicity during antitumor therapy with platinum derivatives.

Lyubimova NV, Topchieva SV, Averinova SG, Kashkadaeva AV, Gorbunova VA, Shiryaev SV, Kushlinskii NE. Lyubimova NV, et al. Among authors: kushlinskii ne. Bull Exp Biol Med. 2000 Sep;130(9):886-91. Bull Exp Biol Med. 2000. PMID: 11177273 Clinical Trial.

5

Expression of phosphatidylinositol-3 kinase in lung cancer.

Gershtein ES, Shatskaya VA, Laktionov KK, Kushlinskii NE, Krasil'nikov MA. Gershtein ES, et al. Among authors: kushlinskii ne. Bull Exp Biol Med. 2000 Dec;130(12):1166-8. doi: 10.1007/BF02682016. Bull Exp Biol Med. 2000. PMID: 11276312

6

Urokinase and tissue plasminogen activators and their inhibitor PAI-1 in human tumors.

Gershtein ES, Kushlinskii NE. Gershtein ES, et al. Among authors: kushlinskii ne. Bull Exp Biol Med. 2001 Jan;131(1):67-72. doi: 10.1023/a:1017542915662. Bull Exp Biol Med. 2001. PMID: 11329087

7

Soluble Fas antigen in the serum of patients with colon cancer.

Kushlinskii NE, Britvin TA, Abbasova SG, Perevoshchikov AG, Prorokov VV, Kostanyan IA, Knysh VI, Lipkin VM. Kushlinskii NE, et al. Bull Exp Biol Med. 2001 Apr;131(4):361-3. doi: 10.1023/a:1017908320634. Bull Exp Biol Med. 2001. PMID: 11550026

8

Tissue- and urokinase-type plasminogen activators and type 1 plasminogen activator inhibitor in melanomas and benign skin pigment neoplasms.

Gershtein ES, Medvedeva SV, Babkina IV, Kushlinskii NE, Trapeznikov NN. Gershtein ES, et al. Among authors: kushlinskii ne. Bull Exp Biol Med. 2001 Jul;132(1):670-4. doi: 10.1023/a:1012532412896. Bull Exp Biol Med. 2001. PMID: 11687850

9

Plasminogen activators and their inhibitor in bone tumors and tumor-like damages.

Kushlinskii NE, Yusifov AI, Gershtein ES, Solov'ev YN, Trapeznikov NN. Kushlinskii NE, et al. Bull Exp Biol Med. 2001 Aug;132(2):780-2. doi: 10.1023/a:1013046432016. Bull Exp Biol Med. 2001. PMID: 11713566

10

Biochemical parameters in the diagnosis and monitoring of neurotoxicity of antitumor cytostatics.

Lyubimova NV, Toms MG, Shakirova IN, Gurina OI, Kushlinskii NE. Lyubimova NV, et al. Among authors: kushlinskii ne. Bull Exp Biol Med. 2001 Nov;132(5):1093-5. doi: 10.1023/a:1017928927399. Bull Exp Biol Med. 2001. PMID: 11865330

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

305 results

Search Page